NYSE · Health Care · Drug Manufacturers - General
BMY
Bristol-Myers Squibb Company
Researches and sells medicines for cancer, cardiovascular disease and immune or neurological conditions.
$63.83-1.27%
Close · 2026-08-14$45$50$55$60$65
NovFebMayAug
$41.13
$68.1052-week range, last close at 84% of the range
- 1W
- -1.38%
- 1M
- +8.70%
- 3M
- +13.25%
- 6M
- +7.37%
- YTD
- +22.33%
- 1Y
- +39.92%
- Avg vol 20d
- 12.2M
- RVOL
- 0.61
- HOLD band
Fundamentalsas of 2026-08-14
- Mkt cap
- $130.39B
- P/E
- 14.1
- Fwd P/E
- 9.7
- EPS
- $4.54
- Div yield
- 3.95%
- Beta
- 0.23
- Employees
- 32.5K
- Next earnings
- 2026-10-29
Rating & verdict historyoldest → newest
100.0% correct+0.19% avg moveBUY 0/0 · HOLD 1/1 · SELL 0/0
| Date | Call | Outcome | Return | Takeaway |
|---|---|---|---|---|
| 2026-08-14 | Subscribers | — | — | Subscribe to read |
| 2026-08-13 | Subscribers | — | — | Subscribe to read |
| 2026-08-12 | Subscribers | — | — | Subscribe to read |
| 2026-08-11 | Subscribers | — | — | Subscribe to read |
| 2026-08-10 | Subscribers |